Michihiro Satoh Selected Research

Michihiro Satoh Research Topics

Disease

23	Hypertension (High Blood Pressure) 01/2022 - 03/2011
7	Stroke (Strokes) 01/2022 - 07/2012
7	Essential Hypertension 08/2019 - 12/2011
5	Chronic Renal Insufficiency 01/2021 - 08/2012
5	Diabetes Mellitus 01/2020 - 01/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 09/2018 - 04/2011
2	Proteinuria 01/2022 - 08/2012
2	Coronary Disease (Coronary Heart Disease) 01/2021 - 03/2015
2	Heart Failure 12/2019 - 01/2018
2	Hypercholesterolemia 12/2013 - 08/2012
2	Hyperaldosteronism (Conn Syndrome) 08/2012 - 03/2011
1	Periodontitis 06/2022
1	Alveolar Bone Loss 06/2022
1	Congenital Abnormalities (Deformity) 01/2022
1	Insulin Resistance 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Fetal Death 06/2020
1	Pre-Eclampsia (Preeclampsia) 06/2020
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020
1	Gout 01/2020
1	Hyperuricemia 01/2020
1	Birth Weight (Birth Weights) 01/2020
1	Myocardial Infarction 08/2018
1	Cognitive Dysfunction 01/2018
1	Acute Coronary Syndrome 01/2018
1	Tooth Loss 01/2018
1	Parkinson Disease (Parkinson's Disease) 11/2016
1	Inflammation (Inflammations) 01/2016
1	Heart Diseases (Heart Disease) 08/2015
1	Hemorrhage 03/2015
1	Ischemic Stroke 03/2015
1	Ischemia 08/2014
1	Autonomic Nervous System Diseases (Dysautonomia) 08/2014
1	Nocturia 01/2014
1	Masked Hypertension 01/2014
1	Cerebral Infarction 01/2012
1	Lacunar Stroke 04/2011
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 04/2011

Drug/Important Bio-Agent (IBA)

19	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 01/2012
7	SaltsIBA 02/2015 - 10/2011
7	AldosteroneIBA 02/2015 - 03/2011
6	SodiumIBA 01/2022 - 03/2011
4	CholesterolIBA 01/2021 - 01/2012
4	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2020 - 08/2015
4	ReninIBA 02/2015 - 03/2011
3	pro-brain natriuretic peptide (1-76)IBA 12/2019 - 08/2015
2	PotassiumIBA 01/2022 - 01/2014
2	Pharmaceutical PreparationsIBA 01/2022 - 08/2014
2	CreatinineIBA 01/2022 - 08/2012
2	Uric Acid (Urate)IBA 01/2021 - 01/2020
2	AngiotensinogenIBA 01/2016 - 06/2012
2	Dietary SodiumIBA 02/2015 - 03/2011
1	antiarrhythmic peptide (AAP)IBA 06/2022
1	ORALIT (ORS)IBA 06/2022
1	CalciumIBA 01/2022
1	AlbuminsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	HomocysteineIBA 01/2022
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Prescription DrugsIBA 01/2020
1	omega-Chloroacetophenone (Mace)IBA 08/2018
1	N 563IBA 03/2017
1	BarbituratesIBA 11/2016
1	Central Nervous System AgentsIBA 11/2016
1	Antipsychotic Agents (Antipsychotics)IBA 11/2016
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2016
1	Irbesartan FDA LinkGeneric 01/2016
1	Telmisartan (Micardis)FDA Link 01/2016
1	Valsartan (Vals)FDA Link 01/2016
1	azilsartanIBA 01/2016
1	olmesartanIBA 01/2016
1	Monocyte Chemoattractant ProteinsIBA 01/2016
1	Losartan (Cozaar)FDA LinkGeneric 01/2016
1	candesartanIBA 01/2016
1	thiobarbituric acidIBA 01/2016
1	4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA 01/2014
1	Eplerenone (Inspra)FDA LinkGeneric 01/2014
1	Bisoprolol (Concor)FDA LinkGeneric 01/2012
1	Prorenin ReceptorIBA 04/2011

Therapy/Procedure

2	Secondary Prevention 01/2019 - 09/2018
1	Therapeutics 01/2022
1	Cesarean Section (Caesarean Section) 06/2020
1	Drug Prescriptions 01/2020
1	Oral Diagnosis (Oral Examination) 01/2018
1	Activities of Daily Living (ADL) 02/2016
1	Self Medication 01/2014